You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 7, July 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Images in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Radiologic Imaging
 •Magnetic Resonance Imaging
 •Alert me on articles by topic

Spinal Cord Swelling in Human T-Lymphotropic Virus 1–Associated Myelopathy/Tropical Spastic Paraparesis

Magnetic Resonance Indication for Early Anti-inflammatory Treatment?

Arch Neurol. 2004;61:1134-1135.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In February 1998, a 43-year-old Brazilian man developed a rapidly progressive spastic paraparesis. Cerebrospinal fluid findings showed a mild inflammatory response, with 21 leukocytes/mm3, 240 mg/dL of protein, and an intrathecal immune production of anti–human T-lymphotropic virus 1 (HTLV-1) antibodies. Subsequently, a positive HTLV-1 serological finding was also confirmed. A magnetic resonance (MR) image of the spine revealed thoracic cord edema, along with several foci of contrast-enhanced lesions (Figure 1). The patient was given interferon alfa for 1 month and referred to our center in July 1998. At that point he was wheelchair bound, and results of his neurological examination revealed a flaccid paraparesis, hyporeflexia in the lower limbs, a left Babinski sign, and loss of vibration sense in the legs. In September 1998, a new MR image showed only thoracic cord atrophy with disappearance of all enhanced lesions (Figure 2). At that time, the . . . [Full Text of this Article]

COMMENT

Marcus Tulius T. Silva, MD, MSc; Abelardo Araújo, MD, PhD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.